| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research &Development | Director
3 companies
Malik Fady Ibraham serves as an EVP Research &Development at CYTK and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 109 sells. Those positions are worth an estimated $11.9M at current prices.
Historically, Malik Fady Ibraham's trades have earned a middling insider score of 55/100 across 77 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -29.7%.
The biggest single holding is CYTK (~$11.8M) as EVP Research &Development. The recent filings there lean toward selling, a net 574,726 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 1,632 | $23.34 | $38,097.08 | -1.1% | |
| Jan 14, 2021 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 12,500 | $19.25 | $240,618.75 | -4.0% | |
| Dec 10, 2020 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 1,052 | $20.13 | $21,176.76 | -0.7% | |
| Nov 12, 2020 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 1,231 | $17.15 | $21,111.65 | -0.8% | |
| Oct 8, 2020 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 1,258 | $17.45 | $21,952.10 | -0.8% | |
| Sep 10, 2020 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 995 | $22.85 | $22,735.75 | -0.6% | |
| Aug 13, 2020 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 599 | $21.85 | $13,088.15 | -0.4% | |
| Jul 9, 2020 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 1,587 | $26.96 | $42,785.52 | -1.0% |